What is CompuMed, Inc. (CMPD) stock price today?

CompuMed, Inc. (CMPD) is currently trading at $6.70, down 0.3% today.

What is CMPD P/E ratio?

CompuMed, Inc.'s P/E ratio is -34.15. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is CMPD return on equity (ROE)?

CompuMed, Inc.'s return on equity (ROE) is -8.06%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is CompuMed, Inc.'s market cap?

CompuMed, Inc. has a market capitalization of $8.64M.

OTC · Medical - Healthcare Information Services

CompuMed, Inc. (CMPD) Stock

$6.70 -0.30% OTC: CMPD Healthcare

CompuMed, Inc. functions as a dedicated provider of advanced telemedicine solutions tailored for organizational clients.

Valuation

Metric	Value
Price	$6.70
Market Cap	$8.64M
P/E Ratio	-34.15
P/B Ratio	2.88
P/S Ratio	1.06
EPS (TTM)	$-0.05
52-Week High	$6.95
52-Week Low	$1.95
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-8.06%
ROA	-5.57%
ROCE	-5.97%
Gross Margin	47.73%
Operating Margin	-2.47%
Net Margin	-3.12%
Debt/Equity	0.20
Current Ratio	2.37

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$6.0M	$6.0M	$6.0M	$6.0M	$8.0M
Operating Profit	$1.0M	$1.0M	$0	$0	$0
Net Profit	$1.0M	$1.0M	$0	$0	$0
EPS	$0.69	$0.30	$-0.02	$0.15	$-0.05
Op Margin	16.0%	8.7%	-0.5%	3.3%	-0.2%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$5.0M	$5.0M	$4.0M	$5.0M	$5.0M
Total Liabilities	$2.0M	$1.0M	$1.0M	$1.0M	$2.0M
Cash	$2.0M	$2.0M	$1.0M	$2.0M	$2.0M
Borrowings	$1.0M	$1.0M	$0	$1.0M	$1.0M

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$1.0M	$1.0M	$1.0M	$1.0M	$1.0M
Investing Cash Flow	$-2.0M	$-2.0M	$-1.0M	$-1.0M	$-2.0M
Financing Cash Flow	$0	$0	$-1.0M	$0	$0
Net Cash Flow	$0	$0	$-1.0M	$0	$0
Free Cash Flow	$1.0M	$0	$0	$0	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.35
EV / EBITDA	12.74
FCF Yield	4.82%
Quick Ratio	2.34
Interest Coverage	-2.98
Return 1Y	81.08%
Return 3Y	248.96%
Return 5Y	34.00%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
CLABFCore One Labs Inc.	$0.00	—	-0.28	$471	0.00%
CNGGFCann Group Limited	$0.00	—	0.27	$2.40M	0.00%
CPMVMosaic ImmunoEngineering Inc.	$0.55	+65.36%	-6.11	$3.98M	0.00%
DOGPDogecoin Cash, Inc.	$0.01	+5.06%	0.12	$1.35M	0.00%
FNAMEvolutionary Genomics, Inc.	$0.00	—	0.00	$1331	0.00%

About CompuMed, Inc.

CompuMed, Inc. functions as a dedicated provider of advanced telemedicine solutions tailored for organizational clients. The company extends vital clinical care services to both individual patients and various medical facilities internationally. Its primary specializations encompass telecardiology and teleradiology services. These enable healthcare institutions worldwide to connect in real-time with U.S. Board-Certified specialists, utilizing sophisticated cloud-based platforms and integrated medical equipment. Beyond these core areas, CompuMed offers extensive enterprise-level telemedicine frameworks. Its telecardiology portfolio includes a wide array of diagnostic interpretations for adult and pediatric patients, covering examinations such as electrocardiograms (ECG), echocardiograms, vascular studies, holter monitoring, nuclear cardiology assessments, and direct video consultations. In the realm of teleradiology, the company delivers expert image analysis, precise transcription, comprehensive reporting, secure data storage, and video consultations for modalities like Vscan, X-ray, ultrasound, mammography, computed tomography (CT), and magnetic resonance imaging (MRI). CompuMed also offers OsteoGram software, a specialized tool that integrates with both standard and digital X-ray systems to aid in the screening, diagnosis, and ongoing management of osteoporosis. Furthermore, the company supplies mobile ECG and ultrasound solutions, which grant patients direct and immediate access to its network of board-certified medical experts, in addition to providing various medical devices. Its clientele spans a diverse range of sectors, including organ procurement organizations, rural healthcare providers, and correctional healthcare facilities. CompuMed, Inc. was founded in 1973 and is based in Los Angeles, California.

CompuMed, Inc. is headquartered in US.

CompuMed, Inc. (CMPD) stock trades at $6.70 with a market capitalization of $8.64M. The stock is valued at a price-to-earnings (P/E) ratio of -34.15, price-to-book of 2.88, price-to-sales of 1.06. Over the past 52 weeks the stock has ranged between $1.95 and $6.95, and currently trades 3.6% below its 52-week high.

On profitability, CompuMed, Inc. generates a return on equity (ROE) of -8.06%, return on capital employed of -5.97%, an operating margin of -2.47%, a net profit margin of -3.12%.

Official website: www.compumedinc.com